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Abstract
Background: The retinoblastoma protein (Rb) plays a central role in the regulation of cell cycle,
differentiation and apoptosis. In cancer cells, ablation of Rb function or its pathway is a consequence
of genetic inactivation, viral oncoprotein binding or deregulated hyperphosphorylation. Some
recent data suggest that Rb relocation could also account for the regulation of its tumor suppressor
activity, as is the case for other tumor suppressor proteins, such as p53.
Results: In this reported study, we present evidence that a fraction of the total amount of Rb
protein can localize to the mitochondria in proliferative cells taken from both rodent and human
cells. This result is also supported by the use of Rb siRNAs, which substantially reduced the amount
of mitochondrial Rb, and by acellular assays, in which [35S]-Methionine-labeled Rb proteins bind
strongly to mitochondria isolated from rat liver. Moreover, endogenous Rb is found in an internal
compartment of the mitochondria, within the inner-membrane. This is consistent with the
protection of Rb from alkaline treatment, which destroys any interaction of proteins that are
weakly bound to mitochondria.
Conclusion: Although a few data regarding an unspecific cytosolic localization of Rb protein have
been reported for some tumor cells, our results are the first evidence of a mitochondrial
localization of Rb. The mitochondrial localization of Rb is observed in parallel with its classic nuclear
location and paves the way for the study of potential as-yet-unknown roles of Rb at this site.
Background
The retinoblastoma protein (Rb) was the first tumor sup-
pressor protein to be identified [1]. Its loss of function is
linked to the development of numerous human cancers
[2]. This protein is a major regulator of cell cycle, differen-
tiation and apoptosis. Many of Rb's effects on cell-cycle
control derive from its ability to interact with and inhibit
the E2F family of transcription factors [3]. Ablation of Rb
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function in both cultured cells and animals, results, as
expected, in deregulated proliferation, but also, more sur-
prisingly, in apoptosis, according to both p53-dependent
and p53-independent signaling pathways [4,5]. However,
some reports demonstrate that Rb can also act as an
inducer of cell death and point to a controversial role for
this protein in the regulation of apoptosis [6].
In normal cells, the activity of Rb predominantly depends
on the level of phosphorylation of the sixteen potential
cdk phosphorylable serine/threonine residues span on the
protein [7,8]. It is assumed that the phosphorylation of
several critical sites is required to abolish the ability of Rb
to interact with E2F factors and to inhibit cell cycle pro-
gression. In cancer cells, three main mechanisms account
for inactivation of the Rb pathway: genetic inactivation,
sequestration by viral oncoproteins (such as T antigen,
E1A or E7) or hyperphosphorylation as a consequence of
perturbations of cdk activities. Caspase-dependent cleav-
age may also play a role in Rb regulation in both cancer
and normal cells [9-11]. Some recent data suggest that Rb
relocation may also regulate its tumor suppressor func-
tion, as observed for other tumor suppressor proteins
(such as p53), which can be inactivated by a nuclear
export mechanism. A nucleocytoplasmic localization of
Rb has already been observed for cells with high levels of
Rb (MEF-Cdk4R24C/R24C) and cytoplasmic sequestration of
Rb has been observed in some cancer cells [12,13].
In this paper, we have evaluated the possibility that dis-
tinct intra-cellular locations of Rb may account for the
contradictory effects of Rb in apoptosis control described
in the literature. To this end, we examined the cellular
localization of Rb in a range of cell types – tumor or oth-
erwise – of human and rat origin, using several experi-
mental procedures (cell and mitochondria fractionation,
cell-free assay), both in the absence and the presence of
stress. Surprisingly, we found that a fraction of Rb is local-
ized in the mitochondria of proliferative cells regardless of
cell malignancy. This is the first evidence of a mitochon-
drial localization of Rb. More specifically, Rb was detected
in an internal compartment of the mitochondria, within
the inner-membrane, data also supported by the incuba-
tion of Rb with mitochondria and alkaline treatment.
Results and discussion
Mitochondrial Rb is detected by cell fractionation studies
Here, we are interested in finding out whether Rb may
also be located in other cell compartments, in addition to
its conventionally reported nuclear localization. To
achieve this, a cellular subfractionation study was first of
all conducted in order to isolate enriched mitochondria
and nuclei fractions from untreated or etoposide-treated
human and rodent cells, such as human primary fibrob-
lasts (HF), human fibrosarcoma cells (HT1080), rat phe-
ochromocytoma cells (PC12) and rat immortalized
fibroblasts (FR3T3). Then the total extract (T) and subcel-
lular fractions (N and M) were loaded on gel and analyzed
using the Western Blot technique (Fig. 1A). Putative con-
tamination of the mitochondrial fractions was monitored
by detecting cytosolic (tubulin) and nuclear (PCNA or
lamin A) marker proteins, and antibodies directed against
COX II or cytochrome c (mitochondrial markers in living
cells) confirmed the enrichment of mitochondrial frac-
tions. Even if nuclear fractions are contaminated to vary-
ing degrees by mitochondria, which are often difficult to
separate using a specific mitochondria isolation method,
mitochondrial fractions are nevertheless not contami-
nated with either nuclei or cytosolic proteins. In this
study, as already outlined, the Rb protein is detected in
nuclear fractions of untreated human cells, yet, surpris-
ingly, a fraction of Rb is also detected in the mitochon-
drial fractions of these cells (Fig. 1A, lane 3 and  5),
suggesting that Rb may also be located at this site in par-
allel with the classically-described nuclear localization.
The graph (Fig. 1A, lower panel) shows that the ratio mito-
chondria/nuclei of Rb level in untreated cells is greater
than those of PCNA (or Lamin A), indicating that most
mitochondrial Rb is not due to a nuclear contamination.
In order to see if this mitochondrial localization of Rb is
challenged by apoptosis induction we used etoposide, a
DNA-damaging drug acting as a topoisomerase II inhibi-
tor, to activate p53. As described in the literature, the
amount of full-length Rb is reduced in nuclear fractions,
and this also seems to be the case for mitochondrial Rb
(Fig 1A, lane 4 and 6). Nevertheless, the etoposide-treated
human or rodent cells display no major change in Rb
nuclear or mitochondrial distribution, as observed by the
fractionation study.
Next we verified that the protein detected in the mito-
chondrial fraction was indeed the Rb protein by transfect-
ing FR3T3 cells with Rb siRNAs or with control siRNAs,
and then we isolated mitochondria using the same sub-
fractionation method as before (Fig. 1B). Incubation with
Rb siRNAs substantially reduced the amount of Rb in the
total extract (53%) (Fig. 1B, upper panel lane 2), as well as
in the mitochondrial fraction (63%) (lower panel lane 2).
Taken together, these data provide direct evidence that a
proportion of total cellular Rb protein is located in the
mitochondria in the living cells taken from rodents or
humans. Furthermore, as mitochondrial Rb has been
detected in primary human cells (HF) (Fig. 1A, upper-left
panel lane 5), we can suggest that this localization occurs
in normal cells and thus is not associated with a trans-
formed character (tumor or immortalized) of the cells we
tested.
Mitochondrial localization of Rb
Consequently, in order to more accurately determine the
exact mitochondrial localization of Rb, we performed aBMC Cell Biology 2009, 10:50 http://www.biomedcentral.com/1471-2121/10/50
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mitochondrial subfractionation study using mitochon-
dria taken from PC12 rodent cells. We used a classic pro-
tocol to separate the mitochondrial outer-membrane
(OM) from the inter-membrane space (IS) and from the
mitoplast (MP, containing both the inner-membrane and
matrix compartments) (Fig. 2). All the fractions were then
investigated for the presence of endogenous Rb by immu-
noblot. The enrichments in each mitochondrial subfrac-
tion were tested by immunoblotting for β-subunits of F1-
ATPase and ANT for the mitoplast fraction and VDAC and
uMtCK for the outer-membrane fraction. The contamina-
tion of mitochondrial subfractions with cytosolic or
nuclear proteins was assessed by detecting Actin and
TFIID. As shown in Fig. 2, Rb is once more detected in the
total mitochondrial fraction (MT, lane 3). At mitochon-
dria, Rb is detected in the mitoplast fraction (MP, lane 5)
of the mitochondria and is absent in the two other mito-
chondrial subfractions (IS and OM, lanes 6 and 7). These
results suggest, firstly, that Rb is located in an internal
compartment (either in the inner-membrane or in the
matrix) and, secondly, that Rb may be transported across
the outer-membrane to its final destination inside the
mitochondria. This could be accomplished by an interac-
tion with mitochondrial transporter complexes located on
the mitochondrial outer-membrane.
Rb protein is localized in mitochondria Figure 1
Rb protein is localized in mitochondria. A. Equal protein amounts (40 μg) of total extract (T), nuclear (N) and mitochon-
drial (M) fractions of human (HT1080 and HF) and rat (PC12 and FR3T3) cells cultured either untreated or etoposide-treated 
(16 h), were loaded onto gel and then immunoblotted with: anti-Rb (G3-245) antibody, the mitochondrial (COX II or cyto-
chrome c), the cytosolic (Tubulin) or the nuclear marker antibodies (PCNA or Lamin A). HyperPh or hypoPh represents the 
phosphorylated state of Rb. (Lower panel) The quantification (Image J software) of the Rb and the PCNA protein levels (or 
Lamin A for FR3T3) in nuclear and mitochondrial fractions illustrated as mitochondrial/nuclear ratio (untreated cells). B. Effect 
of Rb siRNA on the presence of Rb in the mitochondria. FR3T3 cells were incubated for 48 h with Rb siRNA (siRb), control 
siRNAs (siCtrl) or non-transfected (NT). The total cell extract and mitochondrial fractions (20 μg) were loaded onto gel and 
subjected to immunoblotting with anti-Rb (G3-245) antibody. Quantifications were performed with respect to Enolase (for the 
total extract) and COX II (for the mitochondrial extract). Student's tests were performed (**P < 0.01).BMC Cell Biology 2009, 10:50 http://www.biomedcentral.com/1471-2121/10/50
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Study of the in vitro interaction of Rb with mitochondria
Afterwards, to further validate these results, we tested the
in vitro interaction ability of Rb protein with isolated
mitochondria in an acellular assay. For this purpose, we
prepared vectors expressing the full length of Rb, together
with Luciferase (used as negative control) and Bax (used
as positive control, in the presence of tBid) (Fig. 3A), and
analyzed the binding of the corresponding in vitro trans-
lated proteins to mitochondria in a cell-free system. The
fate of [35S]Methionine-labeled proteins was tested by
analyzing the interaction with fresh rat liver mitochondria
from rodent cells according to the protocol previously
described for Bax in the literature [14,15]. As illustrated in
Fig. 3A, the Rb protein (lane 3, mitochondria-bound pro-
teins M1) is found to bind strongly to mitochondria, sim-
ilar to Bax binding (lane 8); only slight amounts of Rb and
Bax remained in the supernatant (lane 2 and 7, non-mito-
chondria-bound proteins S1). In contrast, the non-mito-
chondrial protein Luciferase used as negative control
barely binds to mitochondria (lane 6) and the majority of
the Luciferase remains in the supernatant (lane 5). This
result is consistent with the data from the subcellular frac-
tionation study and suggests that Rb has a high affinity for
mitochondrial binding. It is important to note that the
interaction of Rb with isolated mitochondria was per-
formed in a buffer, which could enable importation of
protein into the mitochondria. Consequently, we cannot
exclude the possibility that Rb might be imported into an
internal compartment in this study.
To answer this question, but also in order to determine
whether Rb is only weakly bound to mitochondria or
whether there is a strong interaction, mitochondria pre-
incubated with full length Rb produced in vitro were sub-
jected to an alkaline treatment. The alkaline treatment is
able to destroy any interaction of proteins that are weakly
bound to mitochondria. This is the case for the Bax bind-
ing previously described [16] and which we used as a pos-
itive control for the alkaline treatment (Fig. 3B, lane 9).
Interestingly, the Rb protein is resistant to alkaline extrac-
tion (Fig. 3B, lane 4), implying that the interaction
between Rb and mitochondria involves strong binding.
These data are in agreement with the result of Rb mito-
plast localization from the mitochondria subfractionation
study, and suggest that Rb may be tightly bound to the
mitochondria inner-membrane, either in the inter-mem-
brane space or in the matrix side. Moreover, we cannot
exclude the possibility that Rb matrix-side location may
play a role in control of the expression of mitochondrial
encoded genes, somehow similar to its nuclear activity.
The recent discovery of Sankaran et al. concerning the
contribution of Rb to the expression of genes encoding
proteins of mitochondrial respiration machinery [17],
together with our findings concerning the mitochondrial
localization of Rb, paves the way for the possibility of Rb
involvement in mitochondrial biogenesis and function.
Lastly, our findings concerning the mitochondrial locali-
zation of Rb do not exclude its classically observed nuclear
localization. Thus, it is important to note that the anti-
body most widely used in the literature to detect Rb – the
G3-245 antibody – recognizes the Rb protein in both
nuclear and mitochondrial fractions using the Western
Blot method. Conversely, in immunofluorescence studies,
the G3-245 antibody we used cannot detect any mito-
chondrial pattern of Rb (see Additional file 1). This may
be explained by the inaccessibility of the antibody to
mitochondrial-located Rb, either because of a masked
epitope or due to the inability of the antibody to bypass
the outer mitochondrial membrane. However, when we
quantified the amount of mitochondrial Rb with respect
to the total Rb from the Western Blots (Fig. 1A) and then
Rb localization at mitochondrial level Figure 2
Rb localization at mitochondrial level. Rb localization at 
mitochondrial level: Mitochondria (MT) were isolated from 
PC12 cells and then subjected to subfractionation into mito-
plast (MP) (the inner-membrane and matrix), inter-mem-
brane space (IS) and outer-membrane (OM) using a 
conventional subfractionation protocol. The total extract 
(T), the nuclear fraction (N) and the cytosolic fraction (C) 
were loaded onto gel in parallel. Equal amounts (40 μg) from 
each fraction were loaded onto gel and submitted to immu-
noblot analysis using anti-Rb (G3-245) antibody to detect 
endogenous Rb. Fraction enrichment was tested using anti-
bodies against the β-subunit of F1-ATPase and ANT for 
mitoplasts, and against VDAC and uMtCK for the outer-
membrane. The cytosolic and nuclear contamination was 
assessed using anti-Actin and anti-TFIID antibodies. HyperPh 
or hypoPh represents the phosphorylated state of Rb. This 
data is representative for 2 independent experiments.BMC Cell Biology 2009, 10:50 http://www.biomedcentral.com/1471-2121/10/50
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normalized to the same number of cells, we found that
mitochondrial Rb level was between 1% to 3% in compar-
ison to the total Rb depending on the cell type. These
results may explain why mitochondrial Rb was not previ-
ously observed.
Conclusion
In summary, our results support the presence of a fraction
of the total amount of Rb protein in the mitochondria in
both rat and human cells. Although some data revealing a
cytosolic location of Rb have already been reported for
tumors exhibiting a high level of cdk4 activity [12,13],
these results are original because, to our knowledge, there
is no data in the literature concerning a mitochondrial
localization of Rb, with most bibliographic data pointing
to a nuclear localization. Nevertheless, this type of loca-
tion is not exhaustive: we found that most of the Rb was
located in nuclear fractions, as previously described. The
mitochondrial localization of Rb has been visualized by
both cell fractionation and in vitro assays. At mitochon-
drial level, Rb seems to reside inside the organelle inas-
much as it was solely detected in the mitoplast fraction.
Altogether, the results present strong evidence for the
mitochondrial localization of a small fraction of cellular
Rb, in parallel to the nuclear localization classically
described, and support the specificity of this interaction.
Methods
Cell lines, cell culture and drugs
FR3T3, HF and HT1080 were grown in Dulbecco's modi-
fied Eagle's medium (DMEM-F12) supplemented with
100  μg/μl penicillin, 100 U/ml streptomycin, 1%
Glutamax and 10% fetal bovine serum under 5% CO2 and
in a humidified atmosphere. PC12 cells were supple-
mented with 5% horse serum. For cell death induction,
etoposide at a final concentration of 50 μg/ml (Sigma,
E1383) was added to freshly plated cultures.
Western Blot reagents
Western Blot was performed according to the method pre-
viously described [18] and the primary antibodies used
were: mouse-monoclonal anti-Rb (G3-245, BD Pharmin-
gen), anti-cytochrome c (BD Pharmingen) and anti-F1-
ATPase (β-subunit MS503, MitoScience); rabbit-polyclo-
nal anti-Enolase (donated by N. Lamande, College de
France, Paris), anti-VDAC and anti-ANT (VDAC and ANT
were donated by C. Brenner, UVSQ, Versailles, France); rat
monoclonal anti-Tubulin (MAS078, Sera-Lab); goat poly-
clonal anti-Lamin A (C-20, Santa Cruz), anti-COX II (K-
Rb interaction with mitochondria Figure 3
Rb interaction with mitochondria. Rb interaction with mitochondria: A. [35S]Met-Rb, -Luciferase and -Bax proteins pro-
duced in vitro were added to purified rat liver mitochondria and then the mitochondria-bound protein fraction (M1) was sepa-
rated from the non-mitochondria-bound protein fraction (S1), then subjected to gel electrophoresis and autoradiography using 
a phosphoimager. In vitro translated proteins, were loaded in parallel as a control (C). B. In vitro translated [35S]Met-Rb, -Luci-
ferase and -Bax were incubated as above and then the mitochondria were alkaline treated (Alk Treat.). Input: translated pro-
teins (C); supernatant containing non-mitochondria-bound proteins (S1); supernatant containing detached proteins after 
alkaline treatment (S2); mitochondria-bound proteins after alkaline treatment (M2). These data are representative for 3 inde-
pendent experiments.BMC Cell Biology 2009, 10:50 http://www.biomedcentral.com/1471-2121/10/50
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20, Santa Cruz), anti-uMtCK (C-18, Santa Cruz), anti-
Actin (sc-8432, Santa Cruz) and anti-TFIID (sc-421, Santa
Cruz). The secondary antibodies (peroxidase-conjugated)
were anti-mouse, anti-rabbit, anti-rat or anti-goat immu-
noglobulin (Biosystem). Immunoreactive bands were
detected by chemiluminescence using an ECL kit (Amer-
sham).
Plasmid construction
Wild-type Rb cDNA was subcloned into pGEM-T vectors
(Promega) after PCR amplification on a human Rb coding
sequence (accession number [EMBL:NM_000321]). The
primers used for PCR amplification are 5'-TCTCGAGCGT-
CATGCCGCCCAAAACCCCCC-3' and 5'-GAAGCTT-
TCATTTCTCTTCCTTGTTTGAGGT-3' (bold: specific Rb
sequence). PCR was performed using standard methods
with DyNAzyme™ EXT DNA polymerase (Finnzymes),
performing 5 PCR cycles at 37°C (denaturation at 94°C
for 30 s, annealing at 37°C for 30 s and extension at 72°C
for 3 min), followed by 25 PCR cycles at 55°C (denatura-
tion at 94°C for 30 s, annealing at 55°C for 30 s and
extension at 72°C for 3 min). The PCR products were
extracted from agarose gel using a JETsorb kit and ligated
into pGEM-T vector using T4-DNA-ligase according to the
manufacturer's instructions (pGEM-T kit, Promega). The
PCR products subcloned in pGEM-T were checked by
sequencing on both strands using T7 and SP6 primers
(MWG biotech).
Acellular assay of Rb interaction
Mitochondria isolation
Mitochondria were prepared from the liver of BD9 female
rats, as described earlier [19]. In brief, liver was harvested
immediately after animal sacrifice and was homogenised
with 5 volumes of an extraction buffer containing 250
mM sucrose, 5 mM Hepes-KOH, pH 7.0, in an Elvehjem
motor driven Teflon pestle (20 strokes, 1,000 rpm). Liver
homogenate was cleared from cell debris and nuclei by a
1,200 × g centrifugation (20 min) and the crude mito-
chondrial fraction was pelleted by a 8,700 × g centrifuga-
tion (15 min). After two washes by 300 mM mannitol, 10
mM MOPS (pH 7.0) crude mitochondrial fractions were
layered onto the top of a discontinuous PercollTM gradi-
ent prepared in 300 mM mannitol, 10 mM MOPS (pH
7.0) and consisting of 2 ml of PercollTM 70%, 3 ml Per-
collTM 30%, 2 ml of PercollTM 18% and 2 ml of Per-
collTM 10%. Gradients were centrifuged (9,000 × g for 45
min), and different mitochondrial fractions were col-
lected at the different PercollTM interfaces. Mitochondria
were washed twice with 300 mM mannitol, 10 mM MOPS
(pH 7.0) and used within a maximum delay of 6 h after
preparation.
In vitro protein synthesis
[35S]Met (Amersham Bioscience) labeled proteins were
synthesized from cDNA using T7 or SP6 RNA polymerase
in vitro transcription followed by translation of the
mRNAs in a rabbit reticulocyte lysate (the TNT-coupled
transcription/translation system, Promega). The molar
concentration of the proteins added to mitochondria was
evaluated from the quantity of [35S]Met incorporated into
the proteins after in vitro translation.
Protein incubation with mitochondria
8 fmol of [35S]Met-labeled proteins were incubated in the
import competent buffer TRB (250 mM sucrose, 80 mM
KCl, 10 mM MgCl2, 10 mM malic acid, 8 mM succinic
acid, 1 mM ATP-Mg2+, 20 mM MOPS, pH 7.5), supple-
mented with 10 mg/ml mitochondria for a 25 μl final vol-
ume. The mixture was incubated for 1 hour at 30°C and
then centrifuged for 15 min at 8,000 × g at 4°C. [35S]Met-
Rb, -Luciferase and -Bax binding with isolated mitochon-
dria was analyzed in SDS-PAGE gel and scanned using a
phosphoimager (Molecular Dynamics, France). Bax was
used in the presence of P13 tBid.
Alkaline treatment
Rb, Luciferase and Bax binding with mitochondrial mem-
brane was determined by extraction with alkaline buffer
(300 mM sucrose, 0.1 Na2CO3, pH 11.3) for 30 min at
4°C, followed by centrifugation for 15 min at 8,000 × g at
4°C, analyzed in SDS-PAGE gel and scanned using a
phosphoimager.
Cell fractionation
Mitochondria were prepared using a conventional differ-
ential centrifugation procedure as described [20]. Briefly,
cells were seeded in 140 mm dishes and incubated at
37°C until they reached 50% confluence, and then were
incubated with or without etoposide for the correspond-
ing times. Then, attached and floating cells were collected
and washed in TD isotonic buffer (135 mM NaCl, 5 mM
KCl, 5 mM Tris-HCl, pH 7.6) and allow to swell for 15
min in ice-cold hypotonic buffer A (250 mM sucrose, 0.1
mM EDTA, 1 mM EGTA, 10 mM Hepes-KOH, pH 7.4, pro-
tease inhibitor cocktail AEBSF (Roche)). Cells disruption
was performed by passing the cells through a 0.4 × 20 mm
needle 10 times. The homogenates were spun at 700 g for
15 min at 4°C and nuclei were separated from the super-
natant and resuspended twice in buffer A at a final con-
centration of 2–3 mg/ml. The supernatant was removed
and spun at 7,000 × g for 20 min at 4°C to separate the
mitochondrial and cytosolic fractions. The mitochondrial
pellets were washed with fractionation buffer B (250 mM
sucrose, 5 mM succinate, 5 mM KH2PO4 10 mM Hepes-
KOH, pH 7.4) and resuspended in fractionation buffer B
to a final protein concentration of 2–3 mg/ml. The pro-
tein concentration was determined using Bradford Rea-
gent (Bio-Rad Laboratories). The Rb protein and
contamination controls for each fraction were assayed by
immunoblot analysis.BMC Cell Biology 2009, 10:50 http://www.biomedcentral.com/1471-2121/10/50
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Cell transfections with siRNA
FR3T3 cells were seeded in 140 mm dishes and incubated
until they reached 50% confluence. Then, 10 nM Rb
siRNA (Rn_Rb1_1_HP siRNA, Qiagen) or negative con-
trol (non-silencing, Qiagen) and HiPerFect Transfection
Reagent (Qiagen) were mixed in culture medium and
then added to the cells, according to the manufacturer's
recommendations (HiPerFect Transfection Reagent Hand-
book, Qiagen). 48 h after transfection, the FR3T3 cells
were subjected to cell fractionation (as above) and gene
silencing at protein level was analyzed using the Western
Blot method.
Mitochondrial subfractionation
Mitochondrial subfractions were prepared from PC12
cells according to a protocol previously described [21].
First, PC12 cells were seeded in 140 mm dishes and incu-
bated at 37°C until they reached 80% confluence, then
cells were collected and washed in a PBS buffer and
allowed to swell for 30 min on an ice-cold isotonic buffer
1 (250 mM sucrose, 1 mM EDTA and 10 mM Tris-HCl, pH
7.5, protease inhibitor AEBSF (Roche)). Cells were then
Dounce (B piston, 100 times passage) homogenized on
ice in buffer 1. Nuclei were pelleted at 1,000 × g and super-
natant centrifuged at 6,000 × g for 15 min at 4°C to pellet
mitochondria. A portion of mitochondria was kept apart
to be loaded on gel in parallel with sub-mitochondria
fractions. Mitochondria pellets were resuspended in
buffer 2 (0.02 BSA, 20 mM K2HPO4, pH 7.4, protease
inhibitor AEBSF) and allowed to swell and Dounce passed
(15 times) to disrupt outer-membrane and then mitoplast
(sub-mitochondrial particles) were collected after centrif-
ugation at 13,000 × g for 15 min at 4°C. Then the super-
natant was ultra-centrifugated for 2 h at 40,000 rpm (50
Ti rotor, OptimaTM LE-80K Ultracentrifuge) at 4°C to
separate the outer-membrane in the pellet from the inter-
membrane space into supernatant. Mitoplast and outer-
membrane fractions were resuspended in Buffer 2. Mito-
chondria along with the sub-mitochondria fractions were
loaded on SDS-PAGE at equal concentrations (40 μg).
Abbreviations
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